GCRC Advisory Committee (GAC)

Voting Members

Marie Badalamente PhD, Orthopaedics Thomas Bilfinger MD, Surgery Turhan Canli PhD, Psychology Wen-Tien Chen PhD, Medical Oncology Chris Cutler DDS, PhD, Dentistry Marian Evinger Assosciate Professor, Pediatrics Joanna Fowler PhD, Biomedical Engineering Leslie G Hyman PhD, Preventive Medicine Gerald Quirk MD, PhD, Obstetrics, Gynecology and Reproductive Medicine Arthur Stone PhD, Psychiatry Thomas Wilson MD, Pediatrics Gene-Jack Wang M.D., M.H.S., Scientist, BNL Joseph Blader PhD, Psychiatry & Behavioral Science Michael Hayman PhD, Molecular Genetics & Microbiology Corinne Jurgens PhD, RN, CS, ANP, School of Nursing Maria Ryan PhD, DDS, Oral Biology & Pathology

Non-Voting Members

Margaret Mc Nurlan Co - Chair, PhD, Surgery Wadie Bahou MD, PhD, Hematology Angela Baumann DO, Credentialing Committee Chair, BNL Tracy Dourdounas RN, MS, CCRC Marie Gelato Program Director - MD, PhD, Medicine William Gunther Manager, Office of Environmental Restoration BNL Mary Johnson IRB Darcy Mallon IRB Administrator BNL Diane Ruenes Sr. Admin Assistant, GCRC Nancy Wyllie Admin Manager - GCRC Hongshik Ahn PhD, Applied Mathematics and Statistics Maureen Hurst RSA, GCRC Wei Zhu PhD, Applied Mathematics, BNL

The GAC supervises and reviews all operations of the GCRC, its Core Laboratories, Informatics Core, and other components; sets general policies; delineates common needs of the GCRC investigators; establishes admission policies; and evaluates projects for GCRC use. Studies on the GCRC must have GAC approval. This approval must be obtained prior to initiation.

The GAC prospectively prioritizes projects for GCRC use to assist the Program Director in allocating resources. In all cases, NIH-funded clinical research is given preference. The GAC is responsible for ensuring implementation of existing NIH policy on the inclusion of women, minorities, and children as study subjects and for approval of DSM plans for all GCRC protocols. In addition, the GAC shall determine if a protocol involves significant risk and, if so, will evaluate and approve the required Data and Safety Monitoring Board (DSMB).

For appropriate classification of industry-related projects, the GAC may request additional materials. The GAC reviews copies of the research agreement between the investigator and industry, an itemized budget, and other relevant correspondence, detailing the drug or other therapeutics or devices supplied.

The GAC periodically reviews all GCRC operations to ensure that GCRC resources are used for the most scientifically justified and relevant projects.

The GAC oversees the GCRC budget.